Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group

This publication has 123 references indexed in Scilit:

• Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
  JAMA, 2002
• Substitution of a Nonnucleoside Reverse Transcriptase Inhibitor for a Protease Inhibitor in the Treatment of Patients with Undetectable Plasma Human Immunodeficiency Virus Type 1 RNA
  Clinical Infectious Diseases, 2000
• Preliminary Guidelines for the Evaluation and Management of Dyslipidemia in Adults Infected with Human Immunodeficiency Virus and Receiving Antiretroviral Therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group
  Clinical Infectious Diseases, 2000
• Impact of Switching from Human Immunodeficiency Virus Type 1 Protease Inhibitors to Efavirenz in Successfully Treated Adults with Lipodystrophy
  Clinical Infectious Diseases, 2000
• Effect of a Combination of Gemfibrozil and Niacin on Lipid Levels
  The Journal of Clinical Pharmacology, 1996
• Safety of combined pravastatin-gemfibrozil therapy
  The American Journal of Cardiology, 1994
• Fluvastatin with and without niacin for hypercholesterolemia
  The American Journal of Cardiology, 1994
• Purpose of Quality Standards for Infectious Diseases
  Clinical Infectious Diseases, 1994
• Comparative efficacy and safety of pravastatin, nicotinic acid and the two combined in patients with hypercholesterolemia
  The American Journal of Cardiology, 1994
• Mitochondrial Myopathy Caused by Long-Term Zidovudine Therapy
  New England Journal of Medicine, 1990